NCT04995562View on ClinicalTrials.gov

Use of Hyperpolarized 129Xe MR Lung Imaging in Infants

PHASE4RecruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 6, 2020

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2027

Conditions

Lungs; Developmental Disorder

Interventions

DRUG

129Xe

Inhaled contrast for MRI

Trial Locations (1)

45229

RECRUITING

Megan Schmitt, Cincinnati

All Listed Sponsors

lead

Children's Hospital Medical Center, Cincinnati

OTHER